LIN TAI-AN (Chief Scientific Officer) received a stock award from SPRINGWORKS THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/8/2024ACC: 0001104659-24-002375
Officer· Chief Scientific Officer
Since Sep 2023
+20.29K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
20.29K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5.29K
Price / share
—
Trade value
—
% of position
22.0%
1/4/2024
24K→29.29K
Total
Net shares
+5.29K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/4/2024 | A · Award | +5.29K | — | — | 22.0% | 24K | 29.29K |
| Total | +5.29K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
15K shares
Shares
+15K
Strike price
38.40
Held after
15K
Exercisable
—
1/4/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock15K shares | 1/4/2024 | A · Award | +15K | 38.40 | — | 15K |